What is the average shipment value for India to Singapore pharmaceutical trade?

$15.4K per consignment across 2,173 shipments.

How many Indian pharmaceutical companies export to Singapore?

74 Indian companies. Largest: Novartis Pharma AG with $16.1M.

How can I find verified Indian pharmaceutical suppliers for Singapore?

TransData Nexus covers 74 active exporters with shipment history and trade values at transdatanexus.com.

Singapore to India Pharmaceutical Import (2026) — $33.5M, 74 Foreign Suppliers | TransData Nexus

Q: What certifications do Indian pharmaceutical exporters need to supply Singapore?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

Singapore to India Pharmaceutical Import (2026) — $33.5M, 74 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Singapore to India

#	Formulation	Value	Share
1	Metformin	$9.5M	28.5%
2	Vildagliptin	$9.5M	28.5%
3	Amino	$3.2M	9.6%
4	Insulin	$2.4M	7.2%
5	Vaccine	$2.1M	6.2%
6	Sodium	$1.2M	3.6%
7	Enoxaparin	$1.2M	3.6%
8	Heparin	$1.2M	3.6%
9	Pembrolizumab	$1.0M	3.1%
10	Teicoplanin	$470.0K	1.4%
11	Probiotics	$349.2K	1.0%
12	Carfilzomib	$173.4K	0.5%
13	Docetaxel	$165.7K	0.5%
14	Fexofenadine	$150.2K	0.4%
15	Protein	$112.2K	0.3%

India imports 20+ pharmaceutical formulations from Singapore with a combined trade value of $33.5M. Key products include Metformin ($9.5M), Vildagliptin ($9.5M), Amino ($3.2M), Insulin ($2.4M), Vaccine ($2.1M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 2,173 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Singapore to India Trade Routes

1Metformin$9.5M

2Vildagliptin$9.5M

3Amino$3.2M

4Insulin$2.4M

5Vaccine$2.1M

6Sodium

Top Singapore Suppliers to India

1Novartis Pharma Ag

$16.1M

2Sanofi-aventis Singapore Pte Ltd

$6.7M

3Fresenius Kabi (singapore) Pte Ltd.

$3.3M

4Novartis Pharma Ag

$2.9M

5Merck Sharp & Dohme Asia Pacific Services Pte Ltd,

$1.3M

Trade Statistics

Total Value$33.5M

Shipments2,173

Indian Exporters74

Singapore Buyers60

Avg Shipment$15K

Products61

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

What is the total value of India's pharmaceutical export to Singapore?

India exported pharmaceuticals worth $33.5M to Singapore across 2,173 verified shipments.

Who are the top Indian pharmaceutical exporters to Singapore?

1. Novartis Pharma AG — $16.1M. 2. SANOFI-AVENTIS SINGAPORE PTE LTD — $6.7M. 3. FRESENIUS KABI (SINGAPORE) PTE LTD. — $3.3M. Total: 74 suppliers.

Which companies in Singapore import pharmaceuticals from India?

1. NOVARTIS HEALTHCARE PRIVATE LIMITED — $19.1M. 2. SANOFI INDIA LIMITED — $6.8M. 3. FRESENIUS KABI INDIA PRIVATE LIMITED — $3.3M. 60 buyers total.

What pharmaceutical products does India export most to Singapore?

1. Metformin ($9.5M, 28.5%); 2. Vildagliptin ($9.5M, 28.5%); 3. Amino ($3.2M, 9.6%); 4. Insulin ($2.4M, 7.2%); 5. Vaccine ($2.1M, 6.2%)

Which ports handle pharmaceutical shipments from India to Singapore?

Export: . Import: .

Why does Singapore import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $33.5M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Singapore?

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Singapore identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 2,173 verified shipments from 74 Indian exporters to 60 Singapore buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

74 Exporters

60 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Singapore to India Pharmaceutical Import